Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Hair loss gene linked to prostate issues.

Higher DHT in male baldness may protect against prostate cancer.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Finasteride increases hair weight and count in men with hair loss, with best results after four years.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Early balding at 40 increases prostate cancer risk.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Men with enlarged prostates often have more severe baldness.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.